Dr Wesley Blackaby

Dr Wesley Blackaby
Dr Wesley Blackaby
Head of Chemistry and Analytical Sciences

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Tue19  Oct10:50am(10 mins)

Session: Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Room: Hall 1B

Profile of Dr Wesley Blackaby

Wesley Blackaby is Head of Chemistry and Analytical Sciences at Servier, a global and independent pharmaceutical Group. Prior to joining Servier Wesley was formerly VP of Chemistry at STORM Therapeutics (2017 – 2021), leading the chemistry function and helping to demonstrate inhibition of RNA modifying enzymes as a chemically tractable approach to indirectly modulate RNA function for therapeutic benefit. Wesley began his industrial career within process chemistry at Glaxo-Wellcome in Dartford before moving to Merck Sharpe and Dohme (MSD) in 1996. In 2006 he joined BioFocus, initially part of the Galapagos group, and subsequently as Charles River Laboratories, advancing in project leadership roles culminating as Senior Director in Medicinal Chemistry, and was responsible for maintaining large multidisciplinary collaborations, overseeing the delivery of multiple drug discovery projects and pre-clinical candidates. Wesley completed his BSc in Chemistry at the University of Southampton followed by PhD studies at University of Southampton and University College Cardiff.


Please login to send a Private Message

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021